This is, for instance, reflected in the tissue-specific involvement of the histone methyltransferase in tumor-promoting (e.g., PDAC, glioblastoma [15,43]) vs. tumor-suppressive (e.g., colorectal cancer [44]) programs. The gene discussed is PRDM9; the disease is neoplasm.